Table 1.
Baseline characteristics of patients included in the differential proteomic analysis.
| Etiol* | Patient | Gender | Age | EF (%)† | RVDD (cm)‡ | Fibrosis§ | Myocarditis|| |
|---|---|---|---|---|---|---|---|
| CCC | #1 | M | 50 | 11 | 82 | 2+ | 2/3+ |
| CCC | #2 | M | 57 | 29 | 71 | 1+ | 2/3+ |
| CCC | #3 | M | 58 | 29 | 64 | 2+ | 2+ |
| CCC | #4 | M | 59 | 17 | 64 | 2+ | 3+ |
| IC | #1 | M | 49 | 25 | 76 | 1+ | 0 |
| IC | #2 | M | 61 | 33 | 79 | 3+ | 0 |
| IC | #3 | M | 52 | 20 | 62 | 3+ | 0 |
| IC | #4 | M | 55 | 16 | 83 | 2+ | 0 |
| DCM | #1 | M | 53 | 19 | 77 | 1/2+ | 0 |
| DCM | #2 | M | 55 | 25 | 51 | 3+ | 0 |
| DCM | #3 | M | 56 | 16 | 99 | 2+ | 0 |
| DCM | #4 | M | 61 | 27 | 76 | 3+ | 0 |
| N | #1 | M | 17 | na | na | na | na |
| N | #2 | M | 22 | na | na | na | na |
| N | #3 | M | 28 | na | na | na | na |
| N | #4 | M | 40 | na | na | na | na |
*Etiol., Etiology; †EF, Ejection Fraction (reference value, ≥55%); ‡ LVDD, Left Ventricular Diastolic Diameter (reference value, 39-53mm); § and || as rated by histopatology (0, absent; 1 +, mild; 2 +, moderate; 3 +, intense); N, individuals without cardiomyopathies; CCC, chronic Chagas disease cardiomyopathy; DCM, idiopathic dilated cardiomyopathy; IC, ischemic cardiomyopathy; M, Male; na, not applicable or not available.